What we know about the Covid variant EG.5 dubbed ‘Eris’
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.
Similar Posts
Nicole Eggert Says She Has Breast Cancer, ‘Panics’ Over Spread Uncertainty
The former “Baywatch” and “Charles in Charge” star said she is concerned for her 12-year-old daughter amid the actor’s “rough” journey.
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
New COVID variant JN.1 surges to 44% of cases, CDC estimates — even higher in New York, New Jersey
The new COVID-19 variant that scientists call JN.1 now makes up about 44.1% of COVID-19 cases across the country, the Centers for Disease Control and Prevention estimated Friday, marking another week of the fast-spreading variant’s steep rise in the U.S. The increase is more than two times larger than the 21.3% that the CDC now…
Covid inquiry: UK’s public services were ‘depleted’ when Covid hit
The nation’s health was declining and the NHS was struggling by 2020, the Covid inquiry hears.
Ellie Middleton: ‘Learning the way my brain works has changed everything for me’
Author Ellie Middleton on her late ADHD and autism diagnoses.
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…
